X4 Pharmaceuticals Inc’s recently made public that its Officer Ragan Paula acquired Company’s shares for reported $13078.0 on Nov 15 ’24. In the deal valued at $0.41 per share,31,897 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Ragan Paula sold 31,897 shares, generating $17,926 in total proceeds. Upon selling the shares at $0.56, the President and CEO now owns 1,025,816 shares.
Before that, Ragan Paula bought 31,897 shares. X4 Pharmaceuticals Inc shares valued at $17,862 were divested by the Officer at a price of $0.56 per share.
B. Riley Securities downgraded its X4 Pharmaceuticals Inc [XFOR] rating to a Neutral from a a Buy in a research note published on December 12, 2023; the price target was decreased to $1 from $3. Cantor Fitzgerald began covering XFOR with “an Overweight” recommendation on December 22, 2022. Piper Sandler started covering the stock on December 12, 2022. It rated XFOR as “an Overweight”.
Price Performance Review of XFOR
On Monday, X4 Pharmaceuticals Inc [NASDAQ:XFOR] saw its stock fall -8.28% to $0.37. Over the last five days, the stock has lost -44.19%. X4 Pharmaceuticals Inc shares have fallen nearly -55.86% since the year began. Nevertheless, the stocks have fallen -51.67% over the past one year. While a 52-week high of $1.60 was reached on 04/03/24, a 52-week low of $0.26 was recorded on 11/13/24. SMA at 50 days reached $0.5745, while 200 days put it at $0.8485.
Levels Of Support And Resistance For XFOR Stock
The 24-hour chart illustrates a support level at 0.3564, which if violated will result in even more drops to 0.3428. On the upside, there is a resistance level at 0.3868. A further resistance level may holdings at 0.4036. The Relative Strength Index (RSI) on the 14-day chart is 37.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1166, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.00%. Stochastics %K at 31.84% indicates the stock is a holding.
How much short interest is there in X4 Pharmaceuticals Inc?
A steep rise in short interest was recorded in X4 Pharmaceuticals Inc stocks on 2024-10-31, dropping by -2.14 million shares to a total of 11.42 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 13.56 million shares. There was a decline of -18.71%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 23, 2019 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $20 price target.
